Albemarle vs Axalta
Albemarle reported revenue of $5.1 billion in fiscal 2025, about the same as Axalta's $5.1 billion in fiscal 2025. Albemarle's revenue fell 4.4% in its latest year, and Axalta's fell 3.0%. Albemarle had an operating margin of -7.1%, against 14.4% at Axalta. Free cash flow was $692 million at Albemarle and $453 million at Axalta.
Side by side
| Albemarle | Axalta | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $5.1B | $5.1B |
| Revenue growth | −4.4% | −3.0% |
| Revenue growth a year, last 5 years | 10.4% | 6.5% |
| Gross margin | 13.0% | 34.4% |
| Operating margin | −7.1% | 14.4% |
| Net margin | −9.9% | 7.4% |
| Free cash flow | $692M | $453M |
| Free cash flow margin | 13.5% | 8.8% |
| Return on capital | −2.4% | 10.5% |
| Net debt to EBITDA | 5.8x | 2.5x |
| Dividends and buybacks | $190M | $165M |
| Change in diluted share count | 0.1% | −1.5% |
| Last close | $93.42 | $34.17 |
| P/E at the last close | — | 20.0× |
| Insider trades, last 12 months | sold $7.4 million | — |
| Piotroski F-score | 7 of 9 | 7 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AlbemarleAxalta
Operating margin
Percent of revenue
AlbemarleAxalta
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AlbemarleAxalta